BNTC — Benitec Biopharma Cashflow Statement
0.000.00%
Last trade - 00:00- $384.47m
- $306.19m
- 40
- 24
- 100
- 54
Annual cashflow statement for Benitec Biopharma, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.27 | -13.9 | -18.2 | -19.6 | -21.8 |
| Depreciation | |||||
| Non-Cash Items | 0.239 | 0.618 | 0.88 | 0.455 | 0.831 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.126 | 0.008 | 1.04 | 0.714 | 1.17 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -7.54 | -12.8 | -15.9 | -18 | -19.4 |
| Capital Expenditures | -0.095 | -0.221 | -0.013 | -0.001 | -0.179 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.001 | 0 | — | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.094 | -0.221 | -0.013 | -0.001 | -0.179 |
| Financing Cash Flow Items | -0.48 | -3.23 | 0 | -1.87 | -5.89 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 1.77 | 22.5 | 0 | 16 | 68 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -5.92 | 9.97 | -15.7 | -1.59 | 48.4 |